Cost of Biotechnology Research Services
across the UK

# Biotechnology Research Services: Trade Body Accreditation

In the UK, biotechnology research services are primarily regulated and accredited through several key bodies depending on the specific nature of the work. The UK's regulatory framework is overseen by the Human Fertilisation and Embryology Authority (HFEA) for fertility-related research, while the Medicines and Healthcare products Regulatory Agency (MHRA) governs services involving drug development or pharmaceutical testing. For broader research standards, many providers seek accreditation from bodies such as UKAS (UK Accreditation Service), which validates quality management systems to ISO standards, or the Association of Medical Research Charities (AMRC) for those involved in charity-funded research. Additionally, institutional biosafety committees and Research Ethics Committees (RECs) operate within NHS trusts and universities to oversee genetic engineering and human subject research. Understanding which accreditation applies to your specific biotechnology need—whether genetic testing, cell culture, drug screening, or clinical trial support—ensures the provider meets appropriate safety, ethical, and scientific standards.

Verifying a provider's credentials involves checking their official registration with the relevant body and requesting documentation of current accreditation status. Most UK regulatory bodies maintain searchable registers; for example, you can verify MHRA registration online, and UKAS-accredited organisations display their certificate details publicly. It's also worth asking providers directly for evidence of compliance, including quality assurance policies, staff qualifications, insurance details, and any recent audit reports. This verification matters considerably because accredited providers have undergone rigorous independent assessment of their facilities, procedures, competency, and record-keeping. An accredited biotechnology service provider is legally and scientifically accountable, reducing the risk of data loss, sample contamination, or regulatory non-compliance that could invalidate research outcomes or delay clinical development timelines.

Accredited